Nordea Bank Abp (0N4T)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 174.80 |
|---|---|
| 52-week range | 154.03 – 204.30 |
| Return, 1 month / 3 months | −13.8% / −6.9% |
| Return, 1 year / 3 years | +19.6% / +89.3% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 19.7% |
| Worst drawdown (1 year) | -16.4% |
| Average daily value traded | 62.80M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nordea Bank Abp is a Nordic bank based in Helsinki, Finland. It provides banking services to personal customers, small and medium-sized businesses and large corporates, covering everyday accounts, lending, savings, cards, payments and wealth management. Its home markets are the Nordic countries, where it runs branch and digital banking operations, and it also serves customers in the Baltic region. The bank earns income mainly from the interest margin on its lending and from fees for its financial services.
The shares are listed on the London Stock Exchange in UK under the code 0N4T, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nordea Bank Abp (0N4T) trades on the London Stock Exchange in UK. It last closed at SEK 174.80 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 468 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.6% and over the last three months it fell 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.4% | ||
| From 52-week high | -14.1% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.9% | ||
| 6-month return | 5.3% | ||
| 12-month return, skipping the last month | 38.8% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.4% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 62.80M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | −13.8% |
| 3 months | −6.9% |
| 6 months | +5.3% |
| 1 year | +19.6% |
| 3 years | +89.3% |
| 5 years | +144.1% |
Signals
| 50-day / 200-day average | 191.76 / 175.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 13.81 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Aug 2026 | EUR 3.7220 |
| 25 Mar 2026 | EUR 10.3795 |
| 21 Mar 2025 | EUR 10.2996 |
| 22 Mar 2024 | EUR 10.4991 |
| 24 Mar 2023 | EUR 8.9786 |
| 25 Mar 2022 | EUR 7.1487 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.